MatejkoB, CyganekK, KatraB, et al.: Insulin pump therapy is equally effective and safe in elderly and young type 1 diabetes patients. Rev Diabet Stud, 2011; 8:254–258.
2.
HermanWH, IlagLL, JohnsonSL, et al.: A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care, 2005; 28:1568–1573.
3.
Siegel-CzarkowskiL, HeroldKC, GolandRS: Continuous subcutaneous insulin infusion in older patients with type 1 diabetes. Diabetes Care, 2004; 27:3022–3023.
4.
RizviAA, PetryR, ArnoldMB, et al.: Beneficial effects of continuous subcutaneous insulin infusion in older patients with long-standing type 1 diabetes. Endocr Pract, 2001; 7:364–369.
5.
GeddesJ, SchopmanJE, ZammittNN, et al.: Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes. Diabet Med, 2008; 25:501–504.
6.
ChoudharyP, GeddesJ, FreemanJV, et al.: Frequency of biochemical hypoglycaemia in adults with Type 1 diabetes with and without impaired awareness of hypoglycaemia: no identifiable differences using continuous glucose monitoring. Diabet Med, 2010; 27:666–672.
7.
MeneillyGS, CheungE, TuokkoH: Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes. Diabetes, 1994; 43:403–410.
8.
MatykaK, EvansM, LomasJ, et al.: Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care, 1997; 20:135–141.
9.
CarlssonBM, AttvallS, ClementsM, et al.: Insulin pump-long-term effects on glycemic control: an observational study at 10 diabetes clinics in Sweden. Diabetes Technol Ther, 2013; 15:302–307.
10.
JoubertM, MoreraJ, VicenteA, et al.: Cross-sectional survey and retrospective analysis of a large cohort of adults with type 1 diabetes with long-term continuous subcutaneous insulin infusion treatment. J Diabetes Sci Technol, 2014; 8:1005–1010.
11.
SeaquistER, AndersonJ, ChildsB, et al.: Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care, 2013; 36:1384–1395.
12.
GoldAE, MacLeodKM, FrierBM: Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care, 1994; 17:697–703.
13.
CohenND, HongES, Van DrieC, et al.: Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes. Diabetes Technol Ther, 2013; 15:544–549.
14.
PickupJC, SuttonAJ: Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med, 2008; 25:765–774.
15.
MissoML, EgbertsKJ, PageM, et al.: Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev, 2010;(1):CD005103.
16.
ReznikY, CohenO, AronsonR, et al.: Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial. Lancet, 2014; 384:1265–1272.
